drug
oxcarbazepine ER
Marketedupdated 2mo agoby Riconpharma LLC
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 5all catalysts(0)
nothing on the calendar yet
Trials studying oxcarbazepine ER
- phase1Steady-state Pharmacokinetics of BIA 2-093 and Oxcarbazepine in Healthy Volunteers
- phase1Oxcarbazepine 600 mg Tablets Under Fasting Conditions
- phase1Oxcarbazepine 600 mg Tablets Under Non-Fasting Conditions
- —Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies
- phase4The Efficacy and Safety of Oral Oxcarbazepine 300-1200 mg/Day as Adjuvant Therapy in the Treatment of Bipolar Disorder I or II This Study is Not Being Conducted in the United States.
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 1m ago
Found something off?
comments(0)
5-min edit window · permanent after that